Login to Your Account


How to price drug value? Payers, biopharma are still worlds apart

By Marie Powers
News Editor

Thursday, June 9, 2016

Panelists at Allicense 2016, held this year in conjunction with the 2016 BIO International Convention, made clear that the debate over drug cost valuation that escalated last year continues to rage.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription